Results 81 to 90 of about 4,771 (191)
Belinostat is a hydroxamate-type histone deactylase inhibitor (HDACi), which has recently entered phase I and II clinical trials. Microarray-based analysis of belinostat-treated cell lines showed an impact on genes associated with the G2/M phase of the ...
Pezzoli, P. +8 more
core +1 more source
Key Clinical Message Belinostat therapy followed by hematopoietic stem cell transplantation is a promising salvage strategy for heavily pretreated patients with peripheral T‐cell lymphoma.
Sigrid De Wilde, Carlos Graux
doaj +1 more source
Tratamiento del cáncer basado en la epigenética
El cáncer es una enfermedad multifactorial que involucra a factores genéticos, epigenéticos y ambientales en una compleja y no bien comprendida interrelación.
Yarimi Rodríguez Moldón +3 more
doaj +2 more sources
Belinostat là thuốc có khả năng ức chế enzyme HDAC khá tốt, được sử dụng điều trị các khối u ác tính về huyết học và khối u rắn. Trong nghiên cứu này, các dẫn xuất tương tự belinostat đã được tổng hợp thành công qua quy trình đơn giản và hiệu quả, phù ...
Nguyễn Cường Quốc +12 more
doaj
Supplementary Figures S1-S2 from Interactions between Bortezomib and Romidepsin and Belinostat in Chronic Lymphocytic Leukemia ...
Lora B. Kramer (14910317) +5 more
core +1 more source
Histone Deacetylase Inhibitors Are Protective in Acute but Not in Chronic Models of Ototoxicity
Previous studies have reported that modification of histones alters aminoglycoside-induced hair cell death and hearing loss. In this study, we investigated three FDA-approved histone deacetylase (HDAC) inhibitors (vorinostat/SAHA, belinostat, and ...
Chao-Hui Yang +6 more
doaj +1 more source
PURPOSE: Histone deacetylases (HDAC) are involved in the regulation of gene transcription. Aberrant HDAC activity has been associated with tumorigenesis, and, therefore, HDACs are potential targets for the treatment of cancers, including tumors of the ...
Warren, K.E. +6 more
core +1 more source
Novel and Future Therapeutic Drugs for Advanced Mycosis Fungoides and Sézary Syndrome
Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common subtypes of cutaneous T-cell lymphoma. The majority of MF cases present with only patches and plaques and the lesions are usually limited to the skin.
Tomonori Oka, Tomomitsu Miyagaki
doaj +1 more source
Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
The peripheral T-cell lymphomas are a rare and heterogeneous group of mature T-cell lymphomas with limited available therapies. The outcome of frontline chemotherapy regimens has been disappointing, with a long-term survival of only 20%-30%. There is an urgent need to optimize induction therapy by incorporating novel agents that target the dysregulated
Bodiford,Andrew +3 more
openaire +4 more sources
Copyright information:Taken from "The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo"http://www.translational-medicine.com/content/5/1/49Journal of Translational Medicine 2007;5():49-49 ...
Joanne Yoon (37162) +10 more
core +1 more source

